Journal
BIOENGINEERING-BASEL
Volume 10, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/bioengineering10020148
Keywords
vaccine design; SARS-CoV-2; COVID-19; variants
Ask authors/readers for more resources
Vaccination is the most cost-effective means in the fight against infectious diseases. Safe and efficient vaccines are the key elements to stop the pandemic from attacking the world now. This review summarizes state-of-the-art vaccine strategies for controlling the transmission of SARS-CoV-2 and its variants, as well as discusses challenges and future directions for rational vaccine design.
Vaccination is the most cost-effective means in the fight against infectious diseases. Various kinds of vaccines have been developed since the outbreak of COVID-19, some of which have been approved for clinical application. Though vaccines available achieved partial success in protecting vaccinated subjects from infection or hospitalization, numerous efforts are still needed to end the global pandemic, especially in the case of emerging new variants. Safe and efficient vaccines are the key elements to stop the pandemic from attacking the world now; novel and evolving vaccine technologies are urged in the course of fighting (re)-emerging infectious diseases. Advances in biotechnology offered the progress of vaccinology in the past few years, and lots of innovative approaches have been applied to the vaccine design during the ongoing pandemic. In this review, we summarize the state-of-the-art vaccine strategies involved in controlling the transmission of SARS-CoV-2 and its variants. In addition, challenges and future directions for rational vaccine design are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available